✦ LIBER ✦

Benefits and risks of iron therapy for chronic anaemias

✍ Scribed by G. Weiss; V. R. Gordeuk

Book ID: 108711252
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 211 KB
Volume: 35
Category: Article
ISSN: 0014-2972
DOI: 10.1111/j.1365-2362.2005.01529.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Benefits and risks of combination therap

Benefits and risks of combination therapy for hepatitis B

✍ Norah A. Terrault 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB

In successful antiviral therapy of hepatitis B, drug combinations, particularly combinations without cross-resistance, can delay or prevent the emergence of drug-resistant mutants. Because drug-resistant mutants are archived and may limit future therapeutic options, prevention is important for long-

Benefits and risks of interferon therapy

Benefits and risks of interferon therapy for hepatitis B

✍ Robert Perrillo 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB

Alpha interferon is the only licensed drug for hepatitis B with immunomodulatory as well as viral inhibitory properties. Potential advantages of interferon compared to nucleoside analogs include a lack of drug resistance, a finite and defined treatment course, and a higher likelihood for hepatitis B

The risks and benefits of drug therapy

✍ George Destevens 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 609 KB

There is no such thing as an absolutely safe drug. There never was, and I doubt that there will ever be one. Considering this opening statement, I would like to take you through an historical trip on the evolution of drug therapy, what the risks and benefits are, and what the new era of biotechnolog

Risks and Benefits of Hormone Replacemen

Risks and Benefits of Hormone Replacement Therapy

✍ Theodore A. Kotchen; George Mansour; Janette Mansour 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 126 KB

Gene therapy strategies for hemophilia:

Gene therapy strategies for hemophilia: benefits versus risks

✍ Inge Petrus; Marinee Chuah; Thierry VandenDriessche 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB

## Abstract Hemophilia is an inherited bleeding disorder caused by a deficiency of functional clotting factors VIII or IX in the blood plasma. The drawbacks of the classical protein substitution therapy fueled interest in alternative treatments by gene therapy. Hemophilia has been recognized as an

Benefits and risks of nucleoside analog

Benefits and risks of nucleoside analog therapy for hepatitis B

✍ Jules L. Dienstag 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 435 KB

Five oral agents have been approved for the treatment of chronic hepatitis B, ranging in virological potency, clinical efficacy, barrier to resistance, and side-effect profile. The degree of histological, biochemical, and serological improvement with therapy generally corresponds to the degree of su